Nuremberg, Germany

Horst Schreiner


Average Co-Inventor Count = 2.0

ph-index = 9

Forward Citations = 222(Granted Patents)


Location History:

  • Nurnberg, DE (1976 - 1977)
  • Nurnberg, OE (1976 - 1977)
  • Nuremberg, DE (1978 - 1987)
  • Fürth, DE (2014)
  • Fuerth, DE (1997 - 2015)

Company Filing History:


Years Active: 1976-2015

Loading Chart...
27 patents (USPTO):Explore Patents

Title: An Insight into Inventor Horst Schreiner

Introduction

Horst Schreiner, a prominent inventor based in Nuremberg, Germany, has made substantial contributions to the field of clinical study protocols through his innovative ideas. With an impressive portfolio of 27 patents, Schreiner stands out for his dedication to advancing methodologies that ensure quality and compliance in clinical research.

Latest Patents

Among his latest achievements, Schreiner has developed a method and system for measuring the quality of performance and compliance with the protocols of clinical studies. This innovative method involves obtaining criteria for the clinical study and accessing stored clinical data. Following this, the criteria and clinical data are correlated to determine a measure of compliance, thereby establishing a standard for evaluating clinical study integrity.

Career Highlights

Horst Schreiner currently works at Siemens Aktiengesellschaft, where he continues to implement his inventive mindset in real-world applications. His deep understanding of clinical processes and technology has enabled him to create solutions that better support clinical trials, ultimately impacting patient safety and study accuracy.

Collaborations

Throughout his career, Schreiner has collaborated with esteemed colleagues, including Bernhard Rothkegel and Heinrich Hassler. These partnerships have expanded the scope of his inventions and facilitated the development of innovative strategies within their research field.

Conclusion

With 27 patents under his name, Horst Schreiner exemplifies the spirit of innovation in the medical and clinical research industries. His ongoing work at Siemens Aktiengesellschaft showcases his commitment to enhancing clinical study protocols and ensuring high standards of compliance. Schreiner's contributions not only strengthen the foundations of clinical research but also pave the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…